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Objective: The objective was to provide an overall assess-
ment of genetic linkage data of BMI and BMI-defined
obesity using a nonparametric genome scan meta-analysis.
Research Methods and Procedures: We identified 37 pub-
lished studies containing data on over 31,000 individuals
from more than 10,000 families and obtained genome-
wide logarithm of the odds (LOD) scores, non-parametric
linkage (NPL) scores, or maximum likelihood scores
(MLS). BMI was analyzed in a pooled set of all studies, as
a subgroup of 10 studies that used BMI-defined obesity, and
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for subgroups ascertained through type 2 diabetes, hyper-
tension, or subjects of European ancestry.
Results: Bins at chromosome 13q13.2- q33.1, 12q23-q24.3
achieved suggestive evidence of linkage to BMI in the
pooled analysis and samples ascertained for hypertension.
Nominal evidence of linkage to these regions and sugges-
tive evidence for 11q13.3-22.3 were also observed for BMI-
defined obesity. The FTO obesity gene locus at 16q12.2
also showed nominal evidence for linkage. However, over-
all distribution of summed rank p values 0.05 is not
different from that expected by chance. The strongest evi-
dence was obtained in the families ascertained for hyper-
tension at 9q31.1-qter and 12p11.21-q23 (p  0.01).
Conclusion: Despite having substantial statistical power,
we did not unequivocally implicate specific loci for BMI or
obesity. This may be because genes influencing adiposity
are of very small effect, with substantial genetic hetero-
geneity and variable dependence on environmental factors.
However, the observation that the FTO gene maps to one of
the highest ranking bins for obesity is interesting and, while
not a validation of this approach, indicates that other poten-
tial loci identified in this study should be investigated fur-
ther.
Key words: diabetes, hypertension, genetics, meta-anal-
ysis, adiposity
Introduction
The fundamental causes of the rise in obesity in devel-
oped and increasingly in developing countries are unknown
but are thought to relate to a change in energy balance
resulting from the reduced energy expenditure associated
with increasingly sedentary lifestyles and energy dense diets
(1,2). The cultural effects on body weight observed after
people migrate to Western countries and the rapid changes
in the prevalence of obesity (occurring over a single gener-
ation) point to a significant role for environmental causes,
such as socioeconomic and cultural factors (3). Genetic
factors are also very important: substantial evidence for a
genetic component in body weight regulation and adiposity
comes from family, twin, and adoption studies (4,5). Heri-
tability estimates reported from family studies are in the
range of 25% to 40%, and for twin studies in the range of
50% to 80% (6). The complex interaction between inherited
susceptibility to and high-risk environments for developing
obesity mean that approaches to obesity management
should consider all of these causes (7).
Both linkage and association analysis have been used to
attempt to find susceptibility genes for BMI and obesity.
Although the linkage approach in particular has been suc-
cessful in identifying the 6 known single-gene forms of
obesity (8), these are very rare in the general population,
accounting for 1% of cases.
There have been more than 30 genome-wide linkage
scans and several hundred candidate gene association stud-
ies of BMI, and approximately 10 genome-wide linkage
scans of obesity, with a variety of loci and genes implicated
in the disorder (9). However, no susceptibility genes for
common, complex forms of obesity or body weight regula-
tion have been unequivocally identified by these methods.
Individual genome-wide scans for linkage have identified a
number of genetic loci that reach significance criteria, and
some of these have appeared in more than one study, such
as those on chromosomes 2p, 6q, 20p (8). Thus, although
evidence has emerged for specific loci linked to BMI and
obesity (9), none has been consistently implicated in the
majority of genome scan projects.
There are many possible explanations for the observed
inconsistency of results of linkage scans using BMI as a
phenotype. Some of these are methodological, and others
relate to disease etiology, such as locus heterogeneity (i.e.,
more than one separate genetic susceptibility loci), the in-
volvement of different biological pathways, genetic and
environmental differences between populations, variability
in ascertainment criteria, and so on. If there is extensive
heterogeneity, each locus is likely to have a small popula-
tion-wide effect on susceptibility to obesity or on BMI,
which is difficult to detect consistently without very large
samples.
Methodological factors influencing consistency of link-
age studies may include differences in statistical strategies,
the reporting of spurious loci more than once (given the
large number of studies), or differences in sample size and
statistical power (10). Many studies of BMI and obesity
have used small sample sizes, although some large studies
[e.g., National Heart, Lung, and Blood Institute Family
Heart Study (11)] do exist. Strategies that might overcome
these problems include very large population-based linkage
studies, which would increase statistical power, studies that
take into account environmental factors, or genome-wide
association strategies, all of which should be able to detect
genes of smaller effect.
Another possibility is meta-analysis of linkage data,
where the gain in statistical power might overcome the
problems of locus heterogeneity and clarify the role of
individual loci and assist the mapping effort. Consequently,
we applied the rank-based genome scan meta-analysis
(GSMA)1 method (12) to data from the 37 complete ge-
nome scans of BMI, 10 of which are specifically for obesity.
The GSMA is a widely used nonparametric method for
combining results from published genome scans and can be
applied to a combination of studies with different markers,
family structures, and analysis methods. In previous studies,
1 Nonstandard abbreviations: GSMA, genome scan meta-analysis; LOD, logarithm of the
odds; NPL, non-parametric linkage; MLS, maximum likelihood scores; FUSION, Finland-
United States Investigation of NIDDM Genetics.
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the method has identified significant evidence for linkage that
was not evident in the individual studies (13–15). If loci with
small effect, consistent across studies, exist for BMI or obesity,
then this approach would have power to identify them.
Research Methods and Procedures
GSMA Method
The genome was divided into 120 bins of approximately
30 cM. For each study, results were assigned to bins, and the
strongest evidence for linkage within each bin was identi-
fied [e.g., the highest logarithm of odds (LOD)-, Z- or
non-parametric linkage (NPL)-score, or the minimum p
value]. For most studies, evidence for linkage for each bin
[LOD scores, NPL scores, maximum likelihood scores
(MLS), or p values] was taken directly from graphs of
genome-wide linkage results as published in the original
papers. Each graph was imported into a drawing program
(CorelDraw) and overlaid with a grid dividing each chro-
mosome equally into the required number of bins. These
were then ranked in order of evidence for linkage by mea-
suring the peak height within each bin using a graphical
ruler from within the drawing program. For the remaining
studies (16–31), linkage scores were obtained by request
from the study authors, who sent us the full genome-scan
results. A control comparison between ranks estimated this
way, and those from linkage results data for the same study
showed correlation of 0.9. For studies (11,17,20,
23,24,27,32–34) where results included marker names, bins
were determined using predefined markers (see www.k-
cl.ac.uk/depsta/memoge/gsma/bin_definitions.html for list-
ing of bin boundary markers). For all other studies, each
chromosome was divided into equal width bins. Bins are
referred to by chromosome, so “bin 1.4” indicates the fourth
bin on chromosome 1.
The data for the GSMA consist of a maximum linkage
statistic for each study and each bin. Within each study, the
bins are ranked, with the bin achieving maximum evidence
for linkage assigned rank 120. For each bin, the ranks are
then summed across studies, and this summed rank forms
the test statistic for that bin. Under the null hypothesis of no
linkage, the summed rank is the sum of random ranks
chosen from (1, 2, .120) with replacement. Bins with high
summed ranks therefore show evidence for linkage.
The summed rank is tested for significance by simulation,
permuting the bin location of ranks within each study. For
each bin, two tests of significance are performed. The
summed rank p value is equal to the proportion of simulated
bins with summed rank greater or equal to the observed
summed rank. For the ordered rank p value, the “place” of
the bin’s result is noted, and compared with the summed
rank of bins with the same “place” in each simulated
GSMA. So, for the observed highest summed rank, the
ordered rank p value is calculated from the summed ranks of
the bins attaining highest summed rank in each GSMA
simulation. Similarly, the second highest summed rank is
compared with the second highest values in each complete
simulation. Simulation studies have shown that bins with
both significant summed rank and ordered rank p values
have a higher probability of being true linkage findings (35).
We used three different thresholds for significance:
genome-wide significance using a Bonferroni correction for
testing 120 bins (p  0.05/120  0.00042), suggestive
significance expected to occur once in each GSMA study
(p  1/120  0.0083), and nominal significance (p  0.05).
The GSMA analysis was carried using the GSMA soft-
ware (36), available from http://www.kcl.ac.uk/depsta/
memoge/gsma/download.html, with p values based on
10,000 simulations. Analyses were performed unweighted
and weighted for study size. In the weighted analysis, ranks
were multiplied by the study weight before summation
across studies (see below for choice of weighting function).
Ascertainment of Studies
The inclusion criteria for studies in this meta-analysis
were whole genome scans of BMI, analyzed both as quan-
titative and categorical trait. The latter was defined by
dichotomization of BMI at a cut-off point. Our underlying
hypothesis is that the same quantitative trait loci will influ-
ence variation to both BMI and BMI-defined obesity, which
we think is a reasonable hypothesis given the scarcity of
single-gene forms of obesity and the fact that BMI-defined
obesity is very common (BMI 30 in more than 25% of the
U.S. population; http://www.cdc.gov/nccdphp/dnpa/obesity/
trend/maps/index.htm). Studies were identified in two main
ways. Whole genome scans were identified from the obesity
gene database (37) or were selected by using searches for
combinations of “genome scan,” “genome search,” “link-
age,” “BMI,” “body mass index,” and “obesity” using Med-
line, searching between April and July 2004. Some addi-
tional studies were identified on an ad hoc basis, from the
cited references in other papers (30) cited by a previous
meta-analysis (38), or using internet Web-based search en-
gines (39). In addition, we included data from our own
unpublished linkage study of BMI [using the Genetic and
Environmental Nature of Emotional States in Siblings
(GENESIS) sample described by Nash et al. (17)] and one
based on the Finland-United States Investigation of NIDDM
Genetics (FUSION) sample described by Silander et al.
(31). These studies were included because we were aware of
the data from our own study, and data from the Silander et
al., study was offered to us by the investigators as it was a
direct, independent extension of the initial FUSION study
by Watanabe et al. (30). The inclusion of these studies based
on our awareness of them should not introduce bias into our
analysis, as their inclusion is independent of the results
obtained in any specific genome region. All included stud-
ies were identified by July 2004, except Watanabe et al.
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(30), which was included in July 2005. Studies that inves-
tigated linkage in only one region were excluded because
the GSMA method is based on ranking linkage information
across the entire genome.
To ensure that individual studies were included only
once, certain decisions were made about which papers to
include, because some studies are represented in the litera-
ture multiple times (e.g., as an individual study and as part
of a meta-analysis). The data from the Framingham Heart
Study gave a particular problem (40) because several dif-
ferent analyses of genome-wide linkage for BMI have been
carried out on the same data (41–49). A subset of the
Framingham data, however, has also been included as part
of a further study (11) and so this further study, but none of
the additional or original analyses, was included. The results
of Lee et al. (50) were a subset of a second analysis (19) and
were excluded. Genome scans of obesity traits other than
BMI-defined obesity, such as leptin or other anthropometric
measures, were excluded in an attempt to perform a meta-
analysis on a relatively homogenous phenotype. Studies
whose analyses were primarily assessing parent of origin
effects on BMI, e.g., (51), were also excluded.
Despite these strict inclusion criteria, 37 genome-wide
linkage analyses of BMI were eligible for inclusion (11,16–
34,39,52–57). These include the two unpublished genome-
wide linkage analyses of BMI: one based on the sample
included in Nash et al. (17) and one based on the sample of
Silander et al. (31). The study from Wu et al. (53) included
8 scans, which were analyzed separately. 34 of 37 included
studies have authors listed for this meta-analysis as part of
the GSMA-BMI consortium. Table 1 gives details of the
ascertainment criteria and the sampling populations for the
studies included in this analysis, and a summary of the
analysis methods used in the original studies. We were not
able to obtain data from one published study (58).
With regards to the studies with obesity as ascertainment
criteria, 10 published genome-wide linkage studies were
identified, 7 of which used BMI as a categorical trait to
define obesity (i.e., obesity  BMI 30 kg/m2) and 3 of
which used BMI as a quantitative trait. In 2 of the 10
studies, obesity was investigated in childhood/adolescence,
and in these the family ascertainment criteria were a pro-
band with BMI 95th centile and a sibling with BMI 90th
or 95th centile, respectively (29,52). The ascertainment
criteria for the proband in the adult studies were extreme
BMI (35 or BMI 40), and for the siblings, a BMI cut-off
point of between 27 and 40. Table 1 gives further details
of the obesity studies.
Some studies performed different analyses and/or consid-
ered different BMI phenotypes. Stone et al. (20) looked at
three phenotypes (BMI, BMI in females, and BMI in males)
and performed four different parametric and nonparametric
analyses. We used the results of the analysis across both
sexes and considered for each bin the maximum LOD score
obtained from the parametric linkage analysis across dom-
inant, codominant, and recessive models. Li et al. (19)
analyzed 4 different thresholds for obesity status; we used
the linkage results from only one of these in the meta-
analysis, the cut-off point at BMI 30. The majority of
studies did not examine linkage by sex and did not include
the X chromosome resulting in too few studies to attain
sufficient statistical power for their analysis. Consequently,
the GSMA analysis was not performed separately for males
and females, nor was the X chromosome included. Like-
wise, the majority of studies did not stratify patients by age
but used a range of age groups within and between families,
and only two analyzed children only. Thus, we did not
perform stratification by age.
GSMA Analyses
To identify potential common susceptibility loci for both
BMI and obesity, a combined analysis including all of the
37 genome-wide analyses was performed. For studies where
BMI was analyzed as quantitative trait, weighting by the
number of genotyped individuals was used. This was scaled
to give an average weight of 1. Weights ranged from 0.30 to
4.6. For obesity studies where BMI was analyzed as a
categorical trait, a weighting function of the number of
affected individuals was used, giving a maximum weight of
2.4 and a minimum weight of 0.5. Separate weighting
schemes were chosen to reflect the approximate informa-
tiveness of each individual: for the obesity studies where
BMI was analyzed as a categorical trait, each affected
individual will contribute more information than a geno-
typed individual in the studies where BMI was analyzed as
a continuous trait, whose phenotype is not selected for the
tail of the distribution. For the pooled analysis, adjusted
study weights were used, so analysis consisted of 28 “con-
tinuous trait” studies with a mean weight of 1, and 7
“categorical trait” studies, with a mean weight of 1.
Two studies, Li et al. (19) and Stone et al. (20), reported
data with BMI analyzed both as a continuous and a cate-
gorical trait, and both analyses were used in the meta-
analysis. In the Li et al. study (19), results from the cate-
gorical and quantitative analysis are quite discordant, so
they were included in the meta-analysis as if they had been
independent studies. However, the two Stone analyses show
a strong concordance in results, each set of results was
therefore weighted by one half the original weighting fac-
tors calculated for the Stone et al. (20) datasets. Genome-
wide linkage for BMI was calculated in FUSION 1 study
(30) separately for subjects with type 2 diabetes and their
unaffected spouses/children; and although the same families
were used, the results are considered independently as study
subjects were only included in one of the two analyses.
Two major sources of heterogeneity in the linkage studies
are the phenotype of ascertainment and population. BMI is
an easily measured phenotype, and in some studies the
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families were originally ascertained for the presence of a
different phenotype (e.g., obesity, type 2 diabetes, hyper-
tension). One assumption of the meta-analysis is that the
genes that regulate BMI are the same in hypertensive and
diabetic populations, and in the different racial and ethnic
groups included. However, restricting the combined analy-
ses to studies with similar ascertainment criteria or to sub-
jects from a similar ethnic background may increase the
power to detect linkage to particular regions. Subgroup
analyses of the families ascertained through obesity, diabe-
tes, and hypertension were therefore performed, with 8
studies included in the diabetes subgroup (18,22,
23,30,31,39,41) and 9 studies in the hypertension subgroup
(32,53). In addition, 27 studies with subjects of European
ancestry were also analyzed separately (11,16–18,20,23–
25,30,31,33,34,46,53–57). Other population groups had too
few studies available for a separate analysis.
Results
Results for the meta-analyses of all of the BMI studies
(pooled analysis) and of the obesity studies, weighted by
study size are shown in Figure 1A and B, which shows
genome-wide results (i.e., with a Bonferroni correction for
testing 120 bins) with thresholds for significance (1%, 5%,
10%). Results for the subgroup analyses (pooled, obesity,
diabetes, hypertension, and subjects with European ances-
try) are shown in Figure 2, which lists bins achieving a
nominally significant summed rank (p value 0.05) for the
weighted (pW) or unweighted analyses (pU). No bin
achieved significant evidence for linkage at a genome-wide
level (p  0.00042), and few bins achieved suggestive
evidence for linkage (p  0.0083). For most analyses, there
was strong consistency across the bins identified in the
weighted and unweighted analysis. We focus on the
weighted analysis in reporting results.
Bins 13.2 or 13.3 reached suggestive evidence for linkage
in the pooled analysis (bin 13.2 pW  0.009; bin 13.3
pW  0.008), and nominal significance in families ascer-
tained through obesity (bin 13.3 pU  0.019), with Euro-
pean ancestry (bin 13.2 pW  0.016; bin 13.3 pW  0.011),
and in families ascertained for hypertension (bin 13.3 pW 
0.029). Significant results in adjacent bins are a common
finding in GSMA studies, and are due to the correlation of
ranks in adjacent bins, particularly when multipoint analysis
methods have been used in the original studies.
Several other regions were implicated by pooled or as-
certainment-specific analyses. Bin 12.5 showed a sugges-
tive evidence for linkage in the pooled analysis (pU 
0.004) and a nominal significance in the families ascer-
tained through obesity or hypertension. The FTO obesity
gene locus at 16q12.2 (59) showed nominal evidence for
linkage in the pooled analysis of obesity in bin 16.3. Bins
2.2, 9.5, 11.3, 11.4, 11.5, 17.2, and 17.3 also achieved a
summed rank p value 0.05 in two of the five different
analyses. Summed rank p values 0.01 were obtained not
only in the pooled analysis (bins 13.2, 13.3, 12.5), but also
in the obesity analysis at bin 11.3 (pU  0.007), for the
families ascertained through diabetes at bins 17.3 (pW 
0.007) and 4.3 (pU  0.001), for the families ascertained
through hypertension at bins 12.3, 9.5, and 12.4 (pW 
0.004, pW  0.007, and pW  0.008, respectively) and for
the European ancestry group at bin 13.3.
The GSMA uses multiple-testing of 120 bins, so about
6 bins would be expected to attain p  0.05 in each analysis.
This is consistent with the number of significant bins in the
BMI (pooled analysis), and in the obesity status, European
ancestry, and diabetic subgroup analyses. No significant
ordered rank p values were observed in these analyses.
However, in the hypertensive subgroup (9 studies), stronger
evidence for linkage was seen, with 3 bins obtaining a
p value 0.01 and six further bins attaining a summed
rank p value pW  0.05. In the hypertension analysis, bins
12.5 and 13.3, which arose across different analyses,
reached also ordered rank p values  0.05, increasing the
evidence of the existence of susceptibility genes in these
regions.
Discussion
We found several regions of the genome that provided
suggestive or nominal evidence of linkage to BMI. Bins at
chromosome 13q13.2-q33.1 (bins 13.2, 13.3) and 12q23-
q24.3 (bin 12.5) achieved a suggestive evidence of linkage
for BMI in both the pooled weighted or unweighted analy-
sis, and nominal evidence in the unweighted analysis of the
obesity studies. In this latter analysis, suggestive evidence
of linkage was observed in the region 11p12-q13.3 (bin
11.3).
However, the results from the GSMA of 37 genome-wide
scans on BMI and of 10 specific genome screens on obesity
do not provide strong evidence for any particular region
being consistently implicated in the genetic contribution to
either trait. This is reflected by the fact that, in both the
pooled and the obesity analyses, the distribution of summed
rank p values 0.05 is not different from that expected by
chance, under the hypothesis of no linkage, with ordered
rank p values 0.05 for each bin. Moreover, our results do
not seem to highlight any common region implicated in both
traits. In contrast, a previous GSMA meta-analysis of link-
age scans for BMI as a continuous trait was based on data
from only five studies (16,18,32,33,58) from 13 studies
initially targeted for inclusion. We included data only from
those studies for which the authors provided data, despite
the fact that this is not necessary where genome-wide data
(for example, in the form of figures) is included in the
publication. The data from the five studies included 2814
individuals from 505 families (38), and using the same
analysis methods, showed strong evidence of linkage to
chromosome 8p. The five studies included were heteroge-
Genome-wide Linkage Studies, Saunders et al.
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neous with respect to both ethnicity and ascertainment,
which were respectively hypertension, osteoporosis diabe-
tes, random house-to-house recruitment, and finally obesity,
familial dyslipidemia, migraine, osteoarthritis, and hyper-
tension. Thus, the fact that Johnson et al. (38) obtained a
positive result whereas we did not is unlikely to result from
reduced heterogeneity in their sample.
The results presented here are therefore somewhat sur-
prising, given that this meta-analysis represents a very large
number of linkage studies, encompassing data from more
than 10,000 families and over 31,000 individuals (including
four of the five studies considered previously) and for two
traits that are substantially heritable. It is not compatible
with common major loci governing BMI and obesity in the
general population but points toward the existence of many
genes of small effect.
The most likely explanation for our failure to find
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Figure 1: Results of the BMI (pooled) and obesity meta-analysis, showing summed rank for each bin (corrected for genome-wide
significance) and confidence limits (10%, 5%, 1%).
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presence of substantial locus heterogeneity (involving sev-
eral biological systems affecting appetite, behavior, activity
levels, metabolism, as well as genetic variation between
ethnic groups and according to ascertainment criteria), ep-
istasis, and age-dependent effects. Obesity in rodents is
clearly highly heterogeneous, where studies of mice indi-
cate the presence of overlapping combinations of main and
epistatic effects at adjacent ages, which have opposite ef-
fects on early and late growth. Body composition traits in
mice seem to be influenced by an interacting network of
multiple quantitative trait loci, which are shared by the body
composition and body weight traits, suggesting that pleiot-
ropy plays an important role in growth and obesity (60).
The failure to find loci with genome-wide significance
could be partly related to the characteristics of BMI as a
phenotype. BMI is the most easily measured proxy for
obesity but 1) is a composite of fat and nonfat mass (the
latter including bone mass), which are not likely to be
regulated in the same way, and 2) may not always represent
body fat consistently since the relationship between BMI
and fat-mass is not always linear and often shows subgroup
differences. Although high BMI values may principally be
because of adiposity, in individuals nearer the mean high
BMI may be more influenced by other features of body
composition such as bone and muscle mass. This may be a
particular problem for population-based studies where the
majority of individuals are not obese and lie close to the
mean. Despite this, it is worth reiterating that BMI is a
highly reproducible and heritable phenotype, and the results
we observe cannot be a result of flaws in the phenotype
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Figure 2: Bins achieving significant evidence for linkage by summed rank p value for weighted (W) and unweighted (U) analysis of all
groups. SR, summed rank; OR, ordered rank. The cM distances shown in column 1 correspond to the Marshfield genetic map.
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alone. Nevertheless, it is likely that more direct measures of
adiposity would improve the consistency of linkage analy-
sis, and it would be interesting to see what a meta-analysis
of a more specific measure of body fat (e.g., percent body
fat, total abdominal fat, or abdominal visceral fat) would
show. However, at present, there are too few linkage studies
of these phenotypes (9) to make a meta-analysis viable, in
our opinion.
The GSMA method itself has several limitations, and
these are discussed in detail elsewhere. The method should
have high power to detect genes that can be detected in a
linkage analysis (35), although it is difficult to assess the
power of this specific study. GSMA might fail to detect
linkage to loci where genetic heterogeneity is present, either
across studies (because of population differences) or within
studies (only a subset of families linked). Tests for hetero-
geneity in the GSMA are available (61) but have very low
power (62). Similarly, the GSMA would miss common
genes with a low sibling recurrence risk that would be easily
detectable in large association studies, such as the insulin-
induced gene 2 (INSIG2) gene, which was recently identi-
fied as a probable susceptibility gene for obesity by ge-
nome-wide association (63). Since the risk allele has an
odds ratio of only 1.2, its effect would be very difficult to
detect by linkage, and indeed INSIG2 maps to 2q14.2,
which was not identified as a locus for BMI or obesity in
this study or in other individual linkage studies of obesity.
Variability of marker density within scans could also
have an effect on the GSMA. Because of this, positive
findings in the GMSA analysis may be conservative but
negative results are less informative; no method can exclude
linkage in any chromosomal region for a complex disorder,
and GSMA data should not be interpreted in this way.
However, despite our lack of formal evidence for BMI
and obesity loci from the meta-analysis, the highest ranking
bins have been identified as candidates from other studies.
This cannot be construed as formal support for the GSMA
results, as BMI and obesity are related to many common
traits and diseases, and coincidence of loci could easily
occur by chance, but are worth noting as they may assist
with mapping, candidate gene analysis, or functional
studies.
Bins 13.2 and 13.3, corresponding to bands 13q13.2-
q33.1, are the most significant results we observed both in
the pooled analysis and in the subgroup with subjects of
European ancestry, and achieved a significant ordered rank
p values for linkage in the families ascertained through
hypertension. One candidate gene from this region is the
5-hydroxy-tryptamine receptor 2A gene polymorphism (5-
HTR2A, 46 cM), that resides on 13q14-q21 near to bin 13.2.
5-HTR2A has been associated with dietary energy and
alcohol intake in obese people (64), and also with anorexia
nervosa (65). Serotonin is a key mediator in the control of
satiety mechanisms. Serotonin reduces food intake and is
probably involved in weight regulation (66).
Bin 2.2 (2p25.1-p23.2) has already shown linkage with
several obesity-related phenotypes in addition to BMI (67),
including skinfold thickness (68), leptin (26,69), and adi-
ponectin levels (70). This region contains the gene en-
coding pro-opiomelanocortin, a locus previously linked to
leptin levels and fat mass in Mexican-American, French,
and black-American cohorts and shown to be mutated in
obese humans. This region also contains the apolipoprotein
B gene (2p24.2), which has been associated with BMI and
percentage body fat (37).
The most interesting results of the analysis are probably
those obtained in the analysis focusing on the families
ascertained through hypertension, which provide strong ev-
idence of linkage. The significant ordered rank p values for
this analysis show that the clustering of significant p values
is more likely to reflect true BMI susceptibility loci in these
regions (35). That this subgroup provides the strongest
evidence for linkage is perhaps surprising, as the subgroup
is quite heterogeneous, with some researchers having ex-
cluded all diabetics in order to focus on “essential” hyper-
tension. On the other hand, many hypertensive subjects also
have a metabolic syndrome. In this analysis, we included 9
studies, 8 of which had already been analyzed together (53),
and so we would expect a concordance in the results.
However, Wu et al. (53) identified a region on chromosome
3q using an identity-by-descent sharing analysis, which we
did not find. This region showed a strong signal in only one
of the 8 included studies. The different meta-analysis meth-
ods used may therefore explain these discordant results. Wu
et al. (53) used both the IBD sharing method and the Fisher
method for meta-analysis, which retain the magnitude of
significance of the original studies, while GSMA is a rank
based statistic and a single region with a strong linkage
signal is less likely to be identified unless it is replicated
across studies. In contrast, the region 12q14–15, identified
in our analysis, was also highlighted in this previous meta-
analysis, although only in the analysis using the Fisher
method, nonetheless indicating that this may well be a
region of true linkage.
The genes mapping to these loci could either be genes
solely relating to BMI, which have nothing to do with
hypertension, genes that have a pleiotropic effect on both
phenotypes, or genes that are primarily hypertension genes
but influence BMI in this population only. A hypertension
candidate gene is also already known to be located in the
region 12q14–15, arginine vasopressin receptor 1A. In the
other regions that we identified here, cyclooxygenase 1 and
dopamine beta-hydroxylase are found in 9q32-q33.3 and
9q34, respectively, corresponding to bin 9.5; angiotensinase
C/Prolyl-CPY is found in 11q14 (bin 11.4) and endothelin
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receptor type B is found in 13q22 (bin 13.3.). No doubt,
candidate genes for BMI could also be identified from these
regions.
Finally, a comment on the the recent discovery of asso-
ciation between type 2 diabetes and obesity and the FTO
gene on chromosome 16 (59). This is one of the most
convincing genetic findings in obesity, having been repli-
cated in large samples sizes both within and independently
of the original study (71,72). FTO maps to 16q12.2, which
is within bin 16.3, one of the highest ranking bins for
obesity in the present study (Figure 1B). This indicates that
the other putative loci identified by this study, which are
orphan loci in the sense that they have no unequivocally
identified underlying gene, should be investigated further.
In summary, results from our meta-analysis, the largest
GSMA study ever performed, failed to find strongly posi-
tive loci for BMI from linkage studies published to date.
However, it does contribute to the body of evidence sup-
porting the involvement of some loci in the complex poly-
genic regulation of BMI. Our findings indicate that BMI is
most likely a highly heterogeneous trait, and as a general
phenotype for linkage and association analysis is inferior to
direct measures of adiposity or body composition, espe-
cially if consistent ascertainment criteria are not used.
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